iREACH Hot Topics: April 23, 2024 This content is restricted to members only. Please login below. Username or Email Address Password Remember Me Log In Lost your password?
iREACH Lunch & Learn: April 16, 2024 This content is restricted to members only. Please login below. Username or Email Address Password Remember Me Log In Lost your password?
iREACH Lunch & Learn: April 2, 2024 This content is restricted to members only. Please login below. Username or Email Address Password Remember Me Log In Lost your password?
iREACH Hot Topics: June 28, 2022 (AIM) This content is restricted to members only. Please login below. Username or Email Address Password Remember Me Log In Lost your password?
iREACH Hot Topics: March 22, 2022 (AIM) This content is restricted to members only. Please login below. Username or Email Address Password Remember Me Log In Lost your password?
iREACH Hot Topics: August 2, 2022 (AIM) This content is restricted to members only. Please login below. Username or Email Address Password Remember Me Log In Lost your password?
iREACH Hot Topics: June 14, 2022 This content is restricted to members only. Please login below. Username or Email Address Password Remember Me Log In Lost your password?
iREACH Hot Topics: May 10, 2022 This content is restricted to members only. Please login below. Username or Email Address Password Remember Me Log In Lost your password?
iREACH Hot Topics: June 21, 2022 This content is restricted to members only. Please login below. Username or Email Address Password Remember Me Log In Lost your password?
First Approved Oral Antiviral Pill for COVID-19 Disease This talking points document, available in Spanish and English, was developed by iREACH Subject Matter Experts Dr. Yabo Beysolow and Lisa Jacques-Carroll to provide detailed information on the first approved oral antiviral pill for COVID-19 disease.